IRIS
PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.487
EU - Europa 8.515
AS - Asia 5.931
AF - Africa 57
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 10
Totale 26.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.424
CN - Cina 5.687
IE - Irlanda 2.595
UA - Ucraina 1.665
IT - Italia 915
DE - Germania 880
FI - Finlandia 857
SE - Svezia 740
GB - Regno Unito 440
FR - Francia 244
SG - Singapore 66
CA - Canada 62
JP - Giappone 58
RU - Federazione Russa 51
MU - Mauritius 40
IN - India 30
NL - Olanda 28
IR - Iran 24
BE - Belgio 19
AU - Australia 17
ES - Italia 16
EU - Europa 13
PT - Portogallo 13
ID - Indonesia 12
CH - Svizzera 11
PL - Polonia 11
HK - Hong Kong 9
SK - Slovacchia (Repubblica Slovacca) 9
EG - Egitto 7
IL - Israele 7
KR - Corea 6
AT - Austria 5
CL - Cile 5
CZ - Repubblica Ceca 5
GR - Grecia 5
PK - Pakistan 5
IQ - Iraq 4
MY - Malesia 4
TR - Turchia 4
TW - Taiwan 4
BR - Brasile 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SO - Somalia 2
TN - Tunisia 2
VN - Vietnam 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
MT - Malta 1
SI - Slovenia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 26.034
Salva come PNG Salva come JPEG
Città #
Dublin 2.593
Chandler 2.494
Jacksonville 2.150
Nanjing 1.723
Ashburn 829
Nanchang 740
Princeton 651
Lawrence 586
Wilmington 540
Hebei 530
Changsha 479
Shenyang 452
Jiaxing 375
Medford 375
Beijing 320
Boardman 316
Tianjin 300
Helsinki 276
San Genesio Ed Uniti 257
Hangzhou 238
Woodbridge 197
Shanghai 177
Milan 159
Ann Arbor 125
Norwalk 107
Verona 107
Falls Church 93
New York 82
Seattle 68
Des Moines 55
Fairfield 49
Houston 47
Toronto 47
Tokyo 45
Singapore 44
Kunming 43
Los Angeles 43
Washington 36
Jinan 32
Chicago 29
Ningbo 29
Tappahannock 29
Zhengzhou 29
Dearborn 28
Pavia 25
Rome 25
Taizhou 20
Changchun 19
Guangzhou 19
Brussels 16
Missoula 15
Pune 14
Lanzhou 13
Mykolayiv 12
Orange 12
Palermo 12
Auburn Hills 11
Borås 11
London 11
Melito di Napoli 8
Piscataway 8
Saint Petersburg 8
Madrid 7
Semarang 7
Turin 7
Zanjan 7
Fuzhou 6
Melbourne 6
Novokuznetsk 6
Redwood City 6
Rzeszów 6
San Francisco 6
Tehran 6
Aduard 5
Brno 5
Kobe 5
Novara 5
Peshawar 5
Phoenix 5
Somma Lombardo 5
Tavira 5
Zola Predosa 5
Alghero 4
Bastia umbra 4
Berlin 4
Brisbane 4
Cambridge 4
Kishangarh 4
Kraków 4
Las Vegas 4
Leeds 4
Legnaro 4
Monmouth Junction 4
Mountain View 4
Padova 4
Parma 4
Redmond 4
Rockville 4
Sydney 4
Taipei 4
Totale 18.370
Salva come PNG Salva come JPEG
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 151
Calcio antagonisti e aritmie da riperfusione miocardica 136
Tachicardia Ventricolare Polimorfa Catecolaminergica 127
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 119
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 100
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 84
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 79
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 78
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 76
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 76
Gene-specific therapy for inherited arrhythmogenic diseases 74
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 73
Spotlight on sudden cardiac death 73
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 73
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 73
Computer simulation of wild-type and mutant human cardiac Na+ current 73
A method of gene transfer for the treatment of recessive CPVT 73
Risk stratification in the Long-QT Syndrome 72
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 72
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 71
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 70
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 69
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 69
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 68
Long QT syndrome and catecholaminergic VT 68
La Sindrome di Brugada 68
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 68
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 68
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 68
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 66
Catecholaminergic Polymorphic Ventricular Tachycardia. 66
Universal definition of the myocardial infarction 66
Inherited arrhythmogenic diseases 66
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 65
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 65
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 65
Inherited arrhythmia: present and future perspectives for genetic therapy 65
Adrenergic Arrhythmogenesis and The Long QT syndrome 65
Idiopathic Ventricular Fibrillation. 65
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 65
Beyond Cohort Selection: An Analytics-Enabled i2b2 65
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 64
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 64
Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary 64
Cardiac Sodium Channel Diseases 63
Proposed Diagnostic Criteria for the Brugada Syndrome. 63
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 63
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 63
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 62
Ryanodine receptor and calsequestrin in arrhythmogenesis: What we have learnt from genetic diseases and transgenic mice 62
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 62
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 62
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 62
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 61
Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology 61
Molecular underpinning of ''good luck'' 61
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 61
SUDDEN CARDIAC DEATH 61
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 61
Gender-specific prescription for cardiovascular diseases? 60
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 60
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 60
ST-Segment Elevation in the Setting of a Febrile Illness. 60
“Cardiac Risk Stratification by NOS1AP Genotyping” 60
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 60
Drug-induced torsades de pointes and implications for drug development. 60
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 60
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 60
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 60
Evaluation of BLS-D training in lay people. 59
From genes to cell therapy: molecular medicine meets clinical EP 59
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 59
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 59
R Engine Cell: integrating R into the i2b2 software infrastructure. 59
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 59
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 59
Gene specific therapy for cardiac disease: the case of long QT Sydnrome 59
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 59
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 59
Gene therapy to treat cardiac arrhythmias 59
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 59
Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder 58
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 58
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 58
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 58
Identificazione delle mutazioni intrageniche 58
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 58
Guidelines in cardiac pacing and resynchronization therapy. 58
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 58
Information extraction from Italian medical reports: An ontology-driven approach 58
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 58
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 57
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 57
Basi genetiche della morte cardiaca improvvisa 57
L-TYPE CALCIUM CHANNEL DISEASE 57
A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction 57
Genetic determinants of cardiac (electric) conduction. 57
2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 57
Postmortem molecular analysis in victims of sudden unexplained death 57
Genetic causes of sudden cardiac death in the young. 57
Totale 6.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.656 2.111 2.802 7 305 8 337 22 389 26 440 202 7
2020/20213.187 357 304 102 307 4 415 18 489 183 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/2025125 125 0 0 0 0 0 0 0 0 0 0 0
Totale 26.426